(Q47281241)

English

Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD.

scientific article published on 11 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

Alzheimer's disease

1 reference

based on heuristic

inferred from title

author name string

Chihiro Tohda

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

Rie Nakada

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

Takuya Urano

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

Akira Okonogi

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

Tomoharu Kuboyama

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

publication date

11 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

International Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

121

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

12

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

641-648

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Plaques, tangles, and memory loss in mouse models of neurodegeneration.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

beta-Secretase as a therapeutic target for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Therapeutic potential of gamma-secretase inhibitors and modulators

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Sominone improves memory impairments and increases axonal density in Alzheimer's disease model mice, 5XFAD.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Neuritic regeneration and synaptic reconstruction induced by withanolide A

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Neuroscience: Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Characterization of anti-neurodegenerative effects of Polygala tenuifolia in Abeta(25-35)-treated cortical neurons.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Failures to reconsolidate memory in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

New insights into the mechanism of Alzheimer amyloid-beta fibrillogenesis inhibition by N-methylated peptides

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Kihi-to, a herbal traditional medicine, improves Abeta(25-35)-induced memory impairment and losses of neurites and synapses

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Repair of amyloid β(25–35)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches.

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid β-induced neurite atrophy

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2011.602809

21 January 2018

Identifiers

10.3109/00207454.2011.602809

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/21770858

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47281241&oldid=1521702376"